Skip to main content

Partially covered self-expanding metal stent for unresectable malignant extrahepatic biliary obstruction: results of a large prospective series

Abstract

Background

Endoscopic biliary stenting is a well-established palliative treatment in patients with unresectable malignant biliary strictures. Obstruction of uncovered self-expanding metal stent (SEMS) due to tumor ingrowth is the most frequent complication. Partially covered SEMS might increase stent patency but could favor complications related to stent covering, such as pancreatitis, cholecystitis, and migration. The aim of this study was to evaluate the efficacy and safety of partially covered SEMS in patients with an unresectable malignant biliary stricture.

Methods

Patients with malignant extrahepatic biliary obstruction treated endoscopically with partially covered SEMS were included in this multicenter, prospective, nonrandomized study.

Results

One hundred ninety-nine patients were endoscopically treated with partially covered SEMS in 32 Spanish hospitals. Clinical success after deep cannulation was 96%. Early complications occurred in 4% (3 pancreatitis, 2 cholangitis, 1 hemorrhage, 1 perforation, and 1 cholecystitis). Late complications occurred in 19.5% (18 obstructions, 10 migrations, 6 cholangitis without obstruction, 3 acute cholecystitis, and 2 pancreatitis), with no tumor ingrowth in any case. Median stent patency was 138.9 ± 112.6 days. One-year actuarial probability of stent patency was 70% and that of nonmigration was 86%. Multivariate analysis showed adjuvant radio- or chemotherapy as the only independent predictive factor of stent patency and previous insertion of a biliary stent was the only predictive factor of migration.

Conclusions

The partially covered SEMS was easily inserted, had a high clinical success rate, and prevented tumor ingrowth. The incidence of possible complications related to stent coverage, namely, migration, pancreatitis, and cholecystitis, was lower than in previously published series.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2

References

  1. Smith AC, Dowset JF, Russell RC, Hatfield AR, Cotton PB (1994) Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet 344:1655–1660

    PubMed  Article  CAS  Google Scholar 

  2. Davids PH, Groen AK, Rauws EA, Tytgat GN, Huibregtse K (1992) Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 340:1488–1492

    PubMed  Article  CAS  Google Scholar 

  3. Kaasis M, Boyer J, Dumas R, Ponchon T, Coumarus D, Delcenserie R, Canard JM, Fritsch J, Rey JF, Burtin P (2003) Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc 57:178–182

    Article  Google Scholar 

  4. Arguedas MR, Heudebert GH, Stinnett AA, Wilcox CM (2002) Biliary stents in malignant obstructive jaundice due to pancreatic carcinoma: a cost-effectiveness analysis. Am J Gastroenterol 97:898–904

    PubMed  Article  Google Scholar 

  5. Gordon RL, Ring EJ, Laberge JM, Doherty MM (1992) Malignant biliary obstruction: treatment with expandable metallic stents: follow-up of 50 consecutive patients. Radiology 182:697–701

    PubMed  CAS  Google Scholar 

  6. Lee BH, Choe DH, Lee JH, Kim KH, Chin SY (1997) Metallic stents in malignant biliary obstruction: prospective long-term clinical results. AJR Am J Roentgenol 168:741–745

    PubMed  CAS  Google Scholar 

  7. Born P, Neuhaus H, Rösch T, Allescher H, Frimberger E, Classen M (1996) Initial experience with a new, partially covered Wallstent for malignant biliary obstruction. Endoscopy 28:699–702

    PubMed  Article  CAS  Google Scholar 

  8. Shim CS, Lee YH, Cho YD, Bong HK, Kim JO, Cho JY, Kim YS, Lee JS, Lee MS, Hwang SG, Shin KM (1998) Preliminary results of a new covered biliary stent for malignant biliary obstruction. Endoscopy 30:345–350

    PubMed  Article  CAS  Google Scholar 

  9. Dumonceau JM, Cremer M, Auroux J, Delhaye M, Devière J (2000) A comparison of Ultraflex Diamond stents and Wallstents for palliation of distal malignant biliary strictures. Am J Gastroenterol 95:670–676

    PubMed  Article  CAS  Google Scholar 

  10. Nakai Y, Isayama H, Komatsu Tsujino T, Toda N, Sasahira N, Yamamoto N, Hirano K, Tada M, Yoshida H, Kawabe T, Omata M (2005) Efficacy and safety of the covered Wallstent in patients with distal malignant biliary obstruction. Gastrointest Endosc 62:742–748

    PubMed  Article  Google Scholar 

  11. Kahaleh M, Tokar J, Conaway M, Brock A, Le T, Adams RB, Yeaton P (2005) Efficacy and complications of covered Wallstents in malignant distal biliary obstruction. Gastrointest Endosc 61(4):528–533

    PubMed  Article  Google Scholar 

  12. Fumex F, Coumaros D, Napoleon B, Barthet M, Laugier R, Yzet T, Le Sidaner A, Desurmont P, Lamouliatte H, Letard JC, Canard JM, Prat F, Rey JF, Ponchon T, Française Société, d’Endoscopie Digestive (2006) Similar performance but higher cholecystitis rate with covered biliary stents: results from a prospective multicenter evaluation. Endoscopy 38(8):787–792

    PubMed  Article  CAS  Google Scholar 

  13. Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Reyers WC, Liguory C, Nickl N (1991) Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 37(3):383–393

    PubMed  Article  CAS  Google Scholar 

  14. Prat F, Chapat O, Ducot Ponchon T, Fritsch J, Choury AD, Pelletier G, Buffet C (1998) Predictive factors for survival of patients with inoperable malignant distal biliary strictures a practical management guideline. Gut 42(1):76–80

    PubMed  Article  CAS  Google Scholar 

  15. Ikeda M, Okada S, Tokuye K, Ueno H, Okusaka T (2001) Prognostic factors in patients with locally advanced pancreatic carcinoma receiving chemoradiotherapy. Cancer 91(3):490–495

    PubMed  Article  CAS  Google Scholar 

  16. Isayama H, Komatsu Y, Tsujino T, Sasahira N, Hirano K, Toda N, Nakai Y, Yamamoto N, Tada N, Yoshida Y, Kawabe T, Omata M (2004) A prospective randomised study of “covered” versus “uncovered” Diamond stents for the management of distal malignant biliary obstruction. Gut 53:729–734

    PubMed  Article  CAS  Google Scholar 

  17. Ornellas LC, Stefanidis G, Chutan R, Gelrud A, Kelleher TB, Pleskow DK (2009) Covered Wallstents for palliation of malignant biliary obstruction: primary stent placement versus reintervention. Gastrointest Endosc 70:676–683

    PubMed  Article  Google Scholar 

  18. Soderlund C, Linder S (2006) Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial. Gastrointest Endosc 63(7):986–995

    PubMed  Article  Google Scholar 

  19. Gregg JA, De Girolami P, Carr-Locke DL (1985) Effects of sphincteroplasty and endoscopic sphincterotomy on the bacteriologic characteristics of the common bile duct. Am J Surg 149:668–671

    PubMed  Article  CAS  Google Scholar 

  20. Ainley CC, Williams SJ, Smith AC, Hatfield AR, Russell RC, Lees WR (1991) Gallbladder sepsis after stent insertion for bile duct obstruction: management by percutaneous cholecystostomy. Br J Surg 78:961–963

    PubMed  Article  CAS  Google Scholar 

  21. Suk KT, Kim HS, Kim JW, Baik SK, Kwon SO, Kim JG, Lee DH, Yoo BM, Kim JH, Moon YS, Lee DK (2006) Risk factors for cholecystitis after metal stent placement in malignant biliary obstruction. Gastrointest Endosc 64(4):522–529

    PubMed  Article  Google Scholar 

Download references

Acknowledgements

This multicenter study was performed by the Collaborating Group of the COBIWA Register. In addition to the authors, the following investigators participated in this study (all institutions are in Spain): José Luis Vazquez, MD, PhD, Hospital Juan Canalejo, A Coruña; Agustí Panadès, MD, Hospital del Mar, Barcelona; Francesc Vida, MD, Fundació Althaia, Manresa; Cándido Villanueva, MD, PhD, Hospital Santa Creu i Sant Pau, Barcelona; Enric Brullet, MD, PhD, and Rafael Campo, MD, PhD, Hospital Parc Taulí, Sabadell; Albert Tomas, MD, PhD, Hospital General de Catalunya, Barcelona; Jorge Espinós, MD, Mútua de Terrassa, Terrassa; Alfredo Juan López, MD, and Luis Yuguero, MD, Hospital General Yagüe, Burgos; Leopoldo Martin, MD, Hospital Universitario Puerta del Mar, Cádiz; Francisco Romper, MD, Hospital Alarcos, Ciudad Real; Gregorio Urdapilleta, MD, Donostia Ospitalea, Guipúzcoa; Oscar Roncero García-Escribano, MD, Hospital La Mancha Centro, Ciudad Real; Juan Francisco De Dios, MD, and Antonio Naranjo, MD, Hospital Universitario Reina Sofía, Córdoba; Jesús Garcia-Cano, MD, Virgen de la Luz, Cuenca; José Luis Cervantes, MD, Complejo Hospitalario San Millán- San Pedro, La Rioja; Jesús Espinel, MD, Hospital de León, León; Leopoldo López, MD, Xeral, Lugo; Miguel Muñoz, MD, Clínica Universitaria de Navarra, Pamplona; Javier Eguaras, MD, Hospital Virgen del Camino, Navarra; Javier Barnecilla, MD, Rio Carrion, Palencia; Antonio Rodríguez, MD, Hospital Universitario de Salamanca, Salamanca; Felipe Martinez, MD, Clínica Santa Isabel, Sevilla; Vicente Sanchiz, MD, Hospital Clinico Universitario de Valencia, Valencia; Vicente Pons, MD, Hospital La Fe, Valencia; Antonio López, MD, Hospital Universitario Dr. Peset, Valencia; Manuel Perez, MD, Hospital Universitario Río Ortega, Valladolid; Victor Manuel Orive, MD, Hospital Basurto, Vizcaya; Carlos de la Serna, MD, and Santiago Jose Rodríguez, MD, Hospital Virgen de la Concha, Zamora.

Conflicts of interest

None.

Author information

Affiliations

Authors

Consortia

Corresponding author

Correspondence to Cristina Gómez-Oliva.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Gómez-Oliva, C., Guarner-Argente, C., Concepción, M. et al. Partially covered self-expanding metal stent for unresectable malignant extrahepatic biliary obstruction: results of a large prospective series. Surg Endosc 26, 222–229 (2012). https://doi.org/10.1007/s00464-011-1858-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-011-1858-z

Keywords

  • Pancreatobiliary
  • Cholangiopancreatography (ERCP)
  • Cancer digestive
  • Stenting
  • Therapeutic
  • Palliation